[vc_empty_space height=”50px”]
[vc_single_image image=”8070″ img_size=”full” alignment=”center”]

The RALI-dx™ COVID-19 Severity Triage Test (Bench-top Analyzer)

  • Helps predict adverse cytokine event or not – with 50-minute result
  • Measures critical biomarker IL-6 level, predictive of “cytokine storm” adverse respiratory event
  • Helps advise clinician to admit patient to hospital or send home
  • Potentially preventing death, unnecessary hospital admissions and related costs.
  • For use in Hospital or Clinic Lab
  • Not yet FDA-authorized for emergency use authorization (EUA)
[vc_single_image image=”8071″ img_size=”full” alignment=”center”]

The RALI-fast™ COVID-19 Severity Triage Test (Point-of-CareAnalyzer)

  • Helps predict adverse cytokine event or not – with 10-minute result
  • Measures critical biomarker IL-6 level, predictive of “cytokine storm” adverse respiratory event
  • Helps advise clinician to admit patient to hospital or send home
  • Potentially preventing death, unnecessary hospital admissions and related costs.
  • For use in Hospital or Clinic Lab
  • Not yet FDA-authorized for emergency use authorization (EUA)

RALI Tests May Help Reduce Hospitalizations and Prevent Overburden of Healthcare System Costs

[vc_single_image image=”8891″ img_size=”full” alignment=”center”]

CDC estimates* that, from October 1, 2019, through April 4, 2020, there have been:

39,000,000 – 56,000,000

flu illnesses

18,000,000 – 26,000,000

flu medical visits

410,000 – 740,000

flu hospitalizations

24,000 – 62,000

flu deaths